Lixing Yang to Cyclin-Dependent Kinases
This is a "connection" page, showing publications Lixing Yang has written about Cyclin-Dependent Kinases.
Connection Strength
1.103
-
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. Nat Cancer. 2024 Dec; 5(12):1885-1901.
Score: 0.882
-
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors. Clin Cancer Res. 2024 Dec 02; 30(23):5445-5458.
Score: 0.221